Listed

Diversified Healthcare Trust

DHCNasdaqCIK 1075415Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$365.4m, Q2 FY2026
Net income−$37.4m, Q2 FY2026
Diversified Healthcare Trust, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m357Revenue, Q3 FY2023, three months to 2023-09-30$356.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure362Revenue, Q4 FY2023, three months to 2023-12-31$361.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure371Revenue, Q1 FY2024, three months to 2024-03-31$370.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure371Revenue, Q2 FY2024, three months to 2024-06-30$371.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure374Revenue, Q3 FY2024, three months to 2024-09-30$373.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure380Revenue, Q4 FY2024, three months to 2024-12-31$379.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure387Revenue, Q1 FY2025, three months to 2025-03-31$386.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure383Revenue, Q2 FY2025, three months to 2025-06-30$382.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure389Revenue, Q3 FY2025, three months to 2025-09-30$388.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure380Revenue, Q4 FY2025, three months to 2025-12-31$379.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure366Revenue, Q1 FY2026, three months to 2026-03-31$366.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure365Revenue, Q2 FY2026, three months to 2026-06-30$365.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Interest expense$m47.8Interest expense, Q3 FY2023, three months to 2023-09-30$47.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure48.9Interest expense, Q4 FY2023, three months to 2023-12-31$48.9m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-26, accession 0001075415-24-000007. Derived: 12-month figure less the 9-month figure.Report this figure57.6Interest expense, Q1 FY2024, three months to 2024-03-31$57.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-06, accession 0001075415-24-000015.Report this figure58.7Interest expense, Q2 FY2024, three months to 2024-06-30$58.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-01, accession 0001075415-24-000023.Report this figure59.4Interest expense, Q3 FY2024, three months to 2024-09-30$59.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure59.5Interest expense, Q4 FY2024, three months to 2024-12-31$59.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure57.8Interest expense, Q1 FY2025, three months to 2025-03-31$57.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure50.9Interest expense, Q2 FY2025, three months to 2025-06-30$50.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure48.9Interest expense, Q3 FY2025, three months to 2025-09-30$48.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure46.9Interest expense, Q4 FY2025, three months to 2025-12-31$46.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure37.0Interest expense, Q1 FY2026, three months to 2026-03-31$37.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure37.1Interest expense, Q2 FY2026, three months to 2026-06-30$37.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Income tax$m0.2Income tax, Q3 FY2023, three months to 2023-09-30$189.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$66.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$187.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure0.2Income tax, Q2 FY2024, three months to 2024-06-30$170.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure0.1Income tax, Q3 FY2024, three months to 2024-09-30$148.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$38.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$49.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure0.8Income tax, Q2 FY2025, three months to 2025-06-30$843.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure0.3Income tax, Q3 FY2025, three months to 2025-09-30$337.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure0.5Income tax, Q4 FY2025, three months to 2025-12-31$514.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2026, three months to 2026-03-31$622.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure1.3Income tax, Q2 FY2026, three months to 2026-06-30$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Net income$m(65.8)Net income, Q3 FY2023, three months to 2023-09-30−$65.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure(103)Net income, Q4 FY2023, three months to 2023-12-31−$102.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(86.3)Net income, Q1 FY2024, three months to 2024-03-31−$86.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure(97.9)Net income, Q2 FY2024, three months to 2024-06-30−$97.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure(98.7)Net income, Q3 FY2024, three months to 2024-09-30−$98.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure(87.4)Net income, Q4 FY2024, three months to 2024-12-31−$87.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Net income, Q1 FY2025, three months to 2025-03-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure(91.6)Net income, Q2 FY2025, three months to 2025-06-30−$91.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure(164)Net income, Q3 FY2025, three months to 2025-09-30−$164.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure(21.2)Net income, Q4 FY2025, three months to 2025-12-31−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(43.3)Net income, Q1 FY2026, three months to 2026-03-31−$43.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure(37.4)Net income, Q2 FY2026, three months to 2026-06-30−$37.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Diluted EPS$ per share(0.28)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figurenot reported(0.36)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure(0.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure(0.41)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure(0.38)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure(0.68)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figurenot reported(0.18)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure(0.16)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Basic EPS$ per share(0.28)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figurenot reported(0.36)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure(0.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure(0.41)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figurenot reported(0.04)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure(0.38)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure(0.68)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figurenot reported(0.18)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure(0.16)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure

Balance sheet

Cash and equivalents$116.8m, Q2 FY2026
Long-term debt$2.44bn, Q2 FY2026
Shareholders' equity$1.58bn, Q2 FY2026
Diversified Healthcare Trust, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m278Cash and equivalents, Q3 FY2023, at 2023-09-30$278.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure246Cash and equivalents, FY2023, at 2023-12-31$245.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure207Cash and equivalents, Q1 FY2024, at 2024-03-31$207.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure266Cash and equivalents, Q2 FY2024, at 2024-06-30$265.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure257Cash and equivalents, Q3 FY2024, at 2024-09-30$256.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure145Cash and equivalents, FY2024, at 2024-12-31$144.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure303Cash and equivalents, Q1 FY2025, at 2025-03-31$302.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure142Cash and equivalents, Q2 FY2025, at 2025-06-30$141.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure201Cash and equivalents, Q3 FY2025, at 2025-09-30$201.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure105Cash and equivalents, FY2025, at 2025-12-31$105.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure122Cash and equivalents, Q1 FY2026, at 2026-03-31$121.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure117Cash and equivalents, Q2 FY2026, at 2026-06-30$116.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Total assets$m5,530Total assets, Q3 FY2023, at 2023-09-30$5.53bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0001075415-23-000035.Report this figure5,446Total assets, FY2023, at 2023-12-31$5.45bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure5,348Total assets, Q1 FY2024, at 2024-03-31$5.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0001075415-24-000015.Report this figure5,333Total assets, Q2 FY2024, at 2024-06-30$5.33bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001075415-24-000023.Report this figure5,285Total assets, Q3 FY2024, at 2024-09-30$5.29bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure5,137Total assets, FY2024, at 2024-12-31$5.14bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure4,996Total assets, Q1 FY2025, at 2025-03-31$5.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure4,756Total assets, Q2 FY2025, at 2025-06-30$4.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure4,684Total assets, Q3 FY2025, at 2025-09-30$4.68bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure4,361Total assets, FY2025, at 2025-12-31$4.36bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure4,268Total assets, Q1 FY2026, at 2026-03-31$4.27bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure4,239Total assets, Q2 FY2026, at 2026-06-30$4.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Total liabilities$m3,089Total liabilities, Q3 FY2023, at 2023-09-30$3.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-01, accession 0001075415-23-000035.Report this figure3,109Total liabilities, FY2023, at 2023-12-31$3.11bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-25, accession 0001075415-25-000012.Report this figure3,099Total liabilities, Q1 FY2024, at 2024-03-31$3.10bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0001075415-24-000015.Report this figure3,184Total liabilities, Q2 FY2024, at 2024-06-30$3.18bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001075415-24-000023.Report this figure3,237Total liabilities, Q3 FY2024, at 2024-09-30$3.24bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure3,178Total liabilities, FY2024, at 2024-12-31$3.18bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure3,048Total liabilities, Q1 FY2025, at 2025-03-31$3.05bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure2,901Total liabilities, Q2 FY2025, at 2025-06-30$2.90bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure2,995Total liabilities, Q3 FY2025, at 2025-09-30$3.00bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure2,696Total liabilities, FY2025, at 2025-12-31$2.70bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure2,647Total liabilities, Q1 FY2026, at 2026-03-31$2.65bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure2,656Total liabilities, Q2 FY2026, at 2026-06-30$2.66bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported3,050Long-term debt, FY2024, at 2024-12-31$3.05bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-02-25, accession 0001075415-25-000012.Report this figurenot reportednot reportednot reported2,444Long-term debt, FY2025, at 2025-12-31$2.44bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure2,443Long-term debt, Q1 FY2026, at 2026-03-31$2.44bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure2,442Long-term debt, Q2 FY2026, at 2026-06-30$2.44bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure
Current portion of debt$m700Current portion of debt, Q3 FY2023, at 2023-09-30$700.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2023-11-01, accession 0001075415-23-000035.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m2,442Shareholders' equity, Q3 FY2023, at 2023-09-30$2.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure2,337Shareholders' equity, FY2023, at 2023-12-31$2.34bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-24, accession 0001075415-26-000013.Report this figure2,249Shareholders' equity, Q1 FY2024, at 2024-03-31$2.25bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure2,149Shareholders' equity, Q2 FY2024, at 2024-06-30$2.15bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure2,048Shareholders' equity, Q3 FY2024, at 2024-09-30$2.05bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure1,959Shareholders' equity, FY2024, at 2024-12-31$1.96bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure1,948Shareholders' equity, Q1 FY2025, at 2025-03-31$1.95bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure1,855Shareholders' equity, Q2 FY2025, at 2025-06-30$1.85bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure1,689Shareholders' equity, Q3 FY2025, at 2025-09-30$1.69bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure1,666Shareholders' equity, FY2025, at 2025-12-31$1.67bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure1,620Shareholders' equity, Q1 FY2026, at 2026-03-31$1.62bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure1,583Shareholders' equity, Q2 FY2026, at 2026-06-30$1.58bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure

Cash flow

Operating cash flow$38.4m, Q2 FY2026
Share repurchases$50.0k, Q2 FY2026
Diversified Healthcare Trust, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(14.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0001075415-24-000031. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure28.6Operating cash flow, Q1 FY2024, three months to 2024-03-31$28.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure44.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$44.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-04, accession 0001075415-25-000033. Derived: 6-month figure less the 3-month figure.Report this figure21.1Operating cash flow, Q3 FY2024, three months to 2024-09-30$21.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure18.2Operating cash flow, Q4 FY2024, three months to 2024-12-31$18.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure(3.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure53.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$53.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure(49.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$49.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure(20.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$20.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure8.3Operating cash flow, Q1 FY2026, three months to 2026-03-31$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure38.4Operating cash flow, Q2 FY2026, three months to 2026-06-30$38.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Dividends paid$m2.4Dividends paid, Q3 FY2023, three months to 2023-09-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2024-11-04, accession 0001075415-24-000031. Derived: 9-month figure less the 6-month figure.Report this figure2.4Dividends paid, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2.4Dividends paid, Q1 FY2024, three months to 2024-03-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure2.4Dividends paid, Q2 FY2024, three months to 2024-06-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-08-04, accession 0001075415-25-000033. Derived: 6-month figure less the 3-month figure.Report this figure2.4Dividends paid, Q3 FY2024, three months to 2024-09-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure2.4Dividends paid, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2.4Dividends paid, Q1 FY2025, three months to 2025-03-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure2.4Dividends paid, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure2.4Dividends paid, Q3 FY2025, three months to 2025-09-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure2.4Dividends paid, Q4 FY2025, three months to 2025-12-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure2.4Dividends paid, Q1 FY2026, three months to 2026-03-31$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure2.4Dividends paid, Q2 FY2026, three months to 2026-06-30$2.4m. XBRL concept us-gaap:PaymentsOfDividendsCommonStock. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m0.4Share repurchases, Q3 FY2023, three months to 2023-09-30$353.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-04, accession 0001075415-24-000031. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-31$7.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.1Share repurchases, Q1 FY2024, three months to 2024-03-31$78.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-30$43.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-04, accession 0001075415-25-000033. Derived: 6-month figure less the 3-month figure.Report this figure0.8Share repurchases, Q3 FY2024, three months to 2024-09-30$781.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-31$2.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure0.1Share repurchases, Q2 FY2025, three months to 2025-06-30$103.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure1.0Share repurchases, Q3 FY2025, three months to 2025-09-30$954.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-03, accession 0001075415-25-000044. Derived: 9-month figure less the 6-month figure.Report this figure0.1Share repurchases, Q4 FY2025, three months to 2025-12-31$82.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-02-24, accession 0001075415-26-000013. Derived: 12-month figure less the 9-month figure.Report this figure0.1Share repurchases, Q1 FY2026, three months to 2026-03-31$88.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure0.1Share repurchases, Q2 FY2026, three months to 2026-06-30$50.0k. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-03, accession 0001075415-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)240.75m, Q2 FY2026
Diversified Healthcare Trust, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares238Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30238,344,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0001075415-23-000035.Report this figure239Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31238,589,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0001075415-24-000015.Report this figure239Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30238,682,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001075415-24-000023.Report this figure239Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30238,892,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0001075415-24-000031.Report this figure239Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31239,193,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-05, accession 0001075415-25-000024.Report this figure239Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30239,326,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-04, accession 0001075415-25-000033.Report this figure240Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30239,667,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure240Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31239,957,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure240Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30240,132,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure240Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30240,385,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0001075415-25-000044.Report this figure241Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31240,689,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001075415-26-000024.Report this figure241Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30240,749,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure

Shares outstanding: 242.13mShares outstanding, period not labelled, at 2026-07-31242,128,988 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0001075415-26-000030.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. Listed shows no prices and gives no investment advice.